Clinical Trial Update: HVPG for Rebleeding Risk Stratification

View source ↗

Summary

This clinical trial update describes the use of hepatic venous pressure gradient (HVPG) for stratifying rebleeding risk in patients with liver cirrhosis and por…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Liver Cirrhosis, Portal Hypertension | Status: COMPLETED